Related Experiment Video
Updated: May 30, 2026

Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions
Published on: October 10, 2016
Structural characterization of the interaction of the polyene antibiotic Amphotericin B with DODAB bicelles and
Tiago R Oliveira1, Carlos R Benatti, M Teresa Lamy
1Universidade de Sao Paulo, Sao Paulo, Brazil.
Abstract:
Amphotericin B (AmB) is widely used in the treatment of systemic fungal infections, despite its toxic effects. Nephrotoxicity, ascribed as the most serious toxic effect, has been related to the state of aggregation of the antibiotic. In search of the increase in AmB antifungal activity associated with low toxicity, several AmB-amphiphile formulations have been proposed. This work focuses on the structural characterization of a specific AmB formulation: AmB associated with sonicated dioctadecyl dimethylammonium bromide (DODAB) aggregates. Here, it was confirmed that sonicated DODAB dispersion is constituted by DODAB bicelles, and that monomeric AmB is much more soluble in bicelles than in DODAB vesicles. A new optical parameter is proposed for the estimation of the relative amount of amphiphile-bound monomeric AmB. With theoretical simulations of the spectra of spin labels incorporated in DODAB bicelles it was possible to prove that monomeric AmB binds preferentially to lipids located at the edges of DODAB bicelles, rigidifying them, and decreasing the polarity of the region. That special binding of monomeric AmB along the borders of bicelles, where the lipids are highly disorganized, could be used in the formulation of other carriers for the antibiotic, including mixtures of natural lipids which are known to form bicelles.
Insights
This study characterizes Amphotericin B (AmB) in DODAB bicelles, finding monomeric AmB binds to bicelle edges. This binding mechanism may reduce AmB toxicity and enhance antifungal efficacy.
Area of Science:
- Biochemistry
- Materials Science
- Pharmacology
Background:
- Amphotericin B (AmB) is a vital antifungal drug but causes significant nephrotoxicity.
- Drug aggregation state is linked to Amphotericin B's toxicity and efficacy.
- Formulating Amphotericin B with amphiphiles aims to improve its therapeutic index.
Purpose of the Study:
- To structurally characterize Amphotericin B (AmB) when formulated with sonicated dioctadecyl dimethylammonium bromide (DODAB) aggregates.
- To investigate the binding site and effects of monomeric AmB within DODAB bicelles.
- To propose a novel method for quantifying amphiphile-bound monomeric AmB.
Main Methods:
- Characterization of sonicated DODAB dispersions using biophysical techniques.
- Solubility studies of monomeric AmB in DODAB bicelles versus vesicles.
- Development and application of a new optical parameter for AmB-amphiphile binding.
- Theoretical simulations of spin-labeled DODAB bicelles to probe AmB binding interactions.
Main Results:
- Sonicated DODAB dispersions were confirmed to form bicelles.
- Monomeric Amphotericin B exhibited higher solubility in DODAB bicelles compared to DODAB vesicles.
- A new optical parameter was developed to estimate amphiphile-bound monomeric AmB.
- Simulations revealed monomeric AmB preferentially binds to DODAB bicelle edges, rigidifying the structure and reducing local polarity.
Conclusions:
- Monomeric Amphotericin B preferentially binds to the disordered lipid edges of DODAB bicelles.
- This specific binding interaction offers a potential strategy for developing less toxic and more effective Amphotericin B formulations.
- The findings support the use of bicelle-forming lipids, including natural lipid mixtures, as carriers for Amphotericin B.
Related Concept Videos
Antifungal Agents
Pinching-off of Coated Vesicles
Inhibitors of Bacterial Protein Synthesis
COP Coated Vesicles
